Actively Recruiting
Rehabilitation of People With Post-tuberculosis Lung Disease
Led by Centro Universitário Augusto Motta · Updated on 2023-11-13
40
Participants Needed
2
Research Sites
217 weeks
Total Duration
On this page
Sponsors
C
Centro Universitário Augusto Motta
Lead Sponsor
R
Rio de Janeiro State University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Tuberculosis (TB) can leave numerous sequelae, where survivors experience a transition from an acute illness to living with a multifaceted chronic illness. Post-TB lung disease (PD-PTB) encompasses lung diseases and pathologies that occur after one or more episodes of TB, which can affect the patient's lung health and cause disabling symptoms that strongly affect their long-term health. In 2020, it was estimated that there were 155 million TB survivors still alive worldwide, with a large proportion of them carrying functional sequelae with profound socioeconomic repercussions. Thus, the aim of this study is to evaluate the effect of pulmonary rehabilitation (PR) on functionality and health-related quality of life (HRQoL) of people with PD-PTB and to build a PD-PTB severity scoring system based on the data. of pre-RP individuals using artificial intelligence technique.
CONDITIONS
Official Title
Rehabilitation of People With Post-tuberculosis Lung Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with post-tuberculosis lung disease who are clinically stable
- Ability to perform more than 80% of training sessions
You will not qualify if you...
- Presence of comorbidities not related to post-tuberculosis lung disease
- Inability to perform the Glittre-ADL test
- Cognitive changes that impair study participation
- Treatment abandonment during pulmonary rehabilitation
- Uncontrolled hypertension or use of psychotropic medications
- Significant limitations due to osteoarthropathy
- Orthopedic surgery within the past year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Agnaldo José Lopes
Rio de Janeiro, Brazil, 22745-271
Actively Recruiting
2
Centro Universitario Augusto Motta
Rio de Janeiro, Brazil, 22745271
Actively Recruiting
Research Team
A
Agnaldo José Lopes, DsC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here